Recent Quotes

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-09
REV		(EXPECTED)2021-08-09

Q1 2021		Est.		Actual		Surprise
EPS		-0.840		-1.080		-0.2400
REV		13.340M		9.461M		-3.879M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
RCUS	Arcus Biosciences	33.51	1.84	5.81%		2.4B

Arcus Biosciences Frequently Asked Questions

How do I buy Arcus Biosciences (RCUS) stock?

You can purchase shares of Arcus Biosciences (NYSE: RCUS) through any online brokerage.

View our list of the best stock brokerages.

Who are Arcus Biosciences's (RCUS) competitors?

Other companies in Arcus Biosciences’s space includes: Zentalis Pharmaceuticals (NASDAQ:ZNTL), Burning Rock Biotech (NASDAQ:BNR), Centessa Pharmaceuticals (NASDAQ:CNTA), Prothena Corp (NASDAQ:PRTA) and OPKO Health (NASDAQ:OPK).

What is the target price for Arcus Biosciences (RCUS) stock?

The latest price target for Arcus Biosciences (NYSE: RCUS) was reported by SVB Leerink on June 24, 2021. The analyst firm set a price target for 63.00 expecting RCUS to rise to within 12 months (a possible 88.00% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for Arcus Biosciences (RCUS)?

The stock price for Arcus Biosciences (NYSE: RCUS) is $33.51 last updated Today at 6:58:30 PM.

Does Arcus Biosciences (RCUS) pay a dividend?

There are no upcoming dividends for Arcus Biosciences.

When is Arcus Biosciences (NYSE:RCUS) reporting earnings?

Arcus Biosciences’s Q2 earnings are confirmed for after-market on August 9, 2021.

Is Arcus Biosciences (RCUS) going to split?

There is no upcoming split for Arcus Biosciences.

What sector and industry does Arcus Biosciences (RCUS) operate in?

Arcus Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.